These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8076367

  • 21. Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.
    Winterfeld G, Hauff P, Görlich M, Arnold W, Fichtner I, Staab HJ.
    J Cancer Res Clin Oncol; 1992; 119(2):91-6. PubMed ID: 1429831
    [Abstract] [Full Text] [Related]

  • 22. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T, Shibata J, Nukatsuka M, Yamada Y.
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 27. Alternate antiestrogens and approaches to the prevention of breast cancer.
    Jordan VC.
    J Cell Biochem Suppl; 1995 Mar; 22():51-7. PubMed ID: 8538210
    [Abstract] [Full Text] [Related]

  • 28. Exploration of the therapeutic potential of the antiestrogen RU 58668 in breast cancer treatment.
    Van de Velde P, Nique F, Brémaud J, Hameau MC, Philibert D, Teutsch G.
    Ann N Y Acad Sci; 1995 Jun 12; 761():164-75. PubMed ID: 7625719
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Steroid hormone levels in patients with advanced breast cancer during therapy with droloxifene: a pilot study.
    Dalski J, Görlich M.
    Tumori; 1996 Jun 12; 82(1):45-7. PubMed ID: 8623503
    [Abstract] [Full Text] [Related]

  • 32. Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
    Kvinnsland S.
    Am J Clin Oncol; 1991 Jun 12; 14 Suppl 2():S46-51. PubMed ID: 1962597
    [Abstract] [Full Text] [Related]

  • 33. Common mechanism for the estrogen agonist and antagonist activities of droloxifene.
    Grasser WA, Pan LC, Thompson DD, Paralkar VM.
    J Cell Biochem; 1997 May 12; 65(2):159-71. PubMed ID: 9136075
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J, Otsuki T, Yamamoto S, Kurosumi M, Nakata T, Akinaga S, Sonoo H.
    Oncology; 1998 Dec 12; 55 Suppl 1():23-34. PubMed ID: 9852399
    [Abstract] [Full Text] [Related]

  • 36. Phase I trial of droloxifene in patients with metastatic breast cancer.
    Buzdar AU, Kau S, Hortobagyi GN, Theriault RL, Booser D, Holmes FA, Walters R, Krakoff IH.
    Cancer Chemother Pharmacol; 1994 Dec 12; 33(4):313-6. PubMed ID: 8281625
    [Abstract] [Full Text] [Related]

  • 37. Japanese early phase II study of droloxifene in the treatment of advanced breast cancer. Preliminary dose-finding study.
    Abe O.
    Am J Clin Oncol; 1991 Dec 12; 14 Suppl 2():S40-5. PubMed ID: 1962596
    [Abstract] [Full Text] [Related]

  • 38. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V.
    Endocrinology; 2001 Feb 12; 142(2):838-46. PubMed ID: 11159857
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.